Ria Purandare
💉 AstraZeneca invests in rare diseases; Novartis hopes to take the STING out; Merck bets on smart biologics
#508 | Bird flu jumps species; Ending the gender gap in wifi; Milk for diabetes
Read More
💉 The APTF comes a step closer to fruition; Cervical cancer gets a lot of money; Africa unites against malaria
#507 | Merck sets up distribution centre in Brazil; Walking is good for your heart; The Arctic loses its ice
Read More
💉 Gingko goes shopping, and doesn't stop; The WHO says the world eats too much glop; Live near a McD's? Stop!
#506 | Takeda to make dengue vaccine in India; SK bio gets WHO prequalification for typhoid shot; IVI sets up shop in Rwanda
Read More
💉 The new big pharma market; Big bucks queue up for Sanofi arm; Novavax makes a settlement
#505 | Hair loss drug to solve heart woes; GSK says injectable better than pills for HIV treatment
Read More
💉 Gilead bets on liver disease; EFTA bats for extended IP; Is long Covid really real?
#504 | The US FDA love affair with Indian manufacturing continues
Read More
💉 CEPI boost for PAHO; Novartis makes a buy; Novo Nordisk makes a buy too
#503 | Dengue comes for Brazil; CAR-T comes for cancer; Climate change comes for us all
Read MoreLuptatum sensibus
Cu qui sed at legere summo mel summo populo inciderint omittantur vel everti no. Id nam possim corrumpit qui admodum.